Gene · 440
Papers1,669
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,669
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The mutation in splicing factor genes correlates with unfavorable prognosis, genomic instability, anti-tumor immunosuppression and increased immunotherapy response in pan-cancer. | Front Cell Dev Biol | 2022 | 36684432 | PubTator, text mining | PubMed |
| The Cold-Adapted, Temperature-Sensitive SARS-CoV-2 Strain TS11 Is Attenuated in Syrian Hamsters and a Candidate Attenuated Vaccine. | Viruses | 2022 | 36680135 | PubTator, text mining | PubMed |
| Targeting DNA Methylation in Leukemia, Myelodysplastic Syndrome, and Lymphoma: A Potential Diagnostic, Prognostic, and Therapeutic Tool. | Int J Mol Sci | 2022 | 36614080 | PubTator, text mining | PubMed |
| A Proteomic Approach Reveals That miR-423-5p Modulates Glucidic and Amino Acid Metabolism in Prostate Cancer Cells. | Int J Mol Sci | 2022 | 36614061 | PubTator, text mining | PubMed |
| Analysis of Enzyme Activity and Cellular Function for the N80S and S480F Asparagine Synthetase Variants Expressed in a Child with Asparagine Synthetase Deficiency. | Int J Mol Sci | 2022 | 36613999 | Swiss-Prot, curated | PubMed |
| Small extracellular vesicles in metabolic remodeling of tumor cells: Cargos and translational application. | Front Pharmacol | 2022 | 36588730 | PubTator, text mining | PubMed |
| Erwinia asparaginase (crisantaspase) increases plasma levels of serine and glycine. | Front Oncol | 2022 | 36578934 | PubTator, text mining | PubMed |
| Ferroptosis and triple-negative breast cancer: Potential therapeutic targets. | Front Oncol | 2022 | 36568247 | PubTator, text mining | PubMed |
| Turbulence of glutamine metabolism in pan-cancer prognosis and immune microenvironment. | Front Oncol | 2022 | 36568190 | PubTator, text mining | PubMed |
Prenatal Identification of a Novel Mutation in the MCPH1 Gene Associated with Autosomal Recessive Primary Microcephaly (MCPH) Using Next Generation Sequencing (NGS): A Case Report and Review of the Literature. | Children (Basel) | 2022 | 36553323 | PubTator, text mining | PubMed |
| Proteome-Wide Identification of RNA-Dependent Proteins in Lung Cancer Cells. | Cancers (Basel) | 2022 | 36551595 | PubTator, text mining | PubMed |
| Dynamic partitioning of branched-chain amino acids-derived nitrogen supports renal cancer progression. | Nat Commun | 2022 | 36539415 | PubTator, text mining | PubMed |
| Clonal transcriptomics identifies mechanisms of chemoresistance and empowers rational design of combination therapies. | Elife | 2022 | 36525288 | PubTator, text mining | PubMed |
| Tamoxifen resistance-related ceRNA network for breast cancer. | Front Cell Dev Biol | 2022 | 36506097 | PubTator, text mining | PubMed |
| Crosstalk of angiogenesis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in colorectal adenocarcinoma. | Front Immunol | 2022 | 36505481 | PubTator, text mining | PubMed |
| Long Non-Coding RNAs Expressed in the Peanut Allergy for Understanding the Pathophysiology of Peanut Allergy Rat Model. | Foods | 2022 | 36496569 | PubTator, text mining | PubMed |
| Ferroptosis-related biomarkers for Alzheimer's disease: Identification by bioinformatic analysis in hippocampus. | Front Cell Neurosci | 2022 | 36467613 | PubTator, text mining | PubMed |
| Identification of Markers for Diagnosis and Treatment of Diabetic Kidney Disease Based on the Ferroptosis and Immune. | Oxid Med Cell Longev | 2022 | 36466094 | PubTator, text mining | PubMed |
| The amino acid and carnitine concentration changes in bronchoalveolar lavage fluid from lung cancer patients. | World J Surg Oncol | 2022 | 36464703 | PubTator, text mining | PubMed |
| Construction and validation of a novel and superior protein risk model for prognosis prediction in esophageal cancer. | Front Genet | 2022 | 36457747 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/440/papers?page=17